Adequacy Rate of Magnesium Citrate Bowel Preparation in a Large Retrospective Cohort

Mohd Amer AlSamman1, Stephanie Leung2, Abdelmoniem Moustafa3

  • 1former Clinical Assistant Professor of Medicine at Alpert Medical School of Brown University; Gastroenterology and Hepatology Fellow, Medstar Georgetown University Hospital, Washington, DC.

Abstract

Insights

Magnesium Citrate (MC) is an effective and inexpensive colonoscopy preparation, showing high adequacy rates in a large study. This widely accessible option compares favorably to other preps for bowel cleansing.

Area of Science:

  • Gastroenterology
  • Medical Practice

Background:

  • Magnesium Citrate (MC) is an accessible, low-cost colonoscopy preparation not FDA-approved.
  • This study evaluated MC's efficacy in a large, private gastroenterology practice.

Purpose of the Study:

  • To retrospectively evaluate the adequacy of Magnesium Citrate (MC) for colonoscopy preparation.
  • To compare MC's effectiveness against other bowel preparations.

Main Methods:

  • A retrospective analysis of 19,173 colonoscopies performed between 2010-2016.
  • Electronic Medical Records were queried for bowel prep used, indication, and preparation adequacy.
  • Adequacy rates were compared using generalized linear modeling and SAS analysis.

Main Results:

  • Magnesium Citrate (MC) in 2-bottle doses achieved high adequacy rates: 98.94% for screening and 99.29% for non-screening colonoscopies.
  • MC in 3-bottle doses showed slightly lower, yet still favorable, adequacy: 90.35% (screening) and 92.92% (non-screening).
  • MC was the most frequently used prep in the study cohort.

Conclusions:

  • Magnesium Citrate (MC) demonstrates adequate bowel preparation for colonoscopy.
  • MC is a well-tolerated, inexpensive option that favorably compares to other preparations.
  • The findings support MC as a viable colonoscopy prep in clinical practice.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
359
Lower GI Series: Barium Enema01:23

Lower GI Series: Barium Enema

A Barium Enema, or a lower GI series, is a specialized radiographic examination designed to visualize the lower gastrointestinal tract, specifically the colon and rectum. This procedure is instrumental in diagnosing various conditions such as colorectal cancer, polyps, diverticulosis, and inflammatory bowel disease.
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
573
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
532